Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines

Melanoma Research

Volumn 16, Issue 3, 2006, Pages 223-234

  Büscher, Kristina ^a   Hahn, Silvia ^b   Hofmann, Maja ^a   Trefzer, Uwe ^a   Özel, Muhsin ^a   Sterry, Wolfram ^a   Löwer, Johannes ^b   Löwer, Roswitha ^b   Kurth, Reinhard ^a   Denner, Joachim ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Endogenous retrovirus; Human endogenous retrovirus K; Malignant melanoma; np9; Rec

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; PRIMER DNA; PROTEIN NP9; PROTEIN REC; REV PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOMA CELL; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SEQUENCE HOMOLOGY; TERATOCARCINOMA; VIRUS PARTICLE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; ENDOGENOUS RETROVIRUSES; EPITOPE MAPPING; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE PRODUCTS, ENV; GENES, ENV; HELA CELLS; HUMANS; IMMUNE SERA; MELANOMA; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; VIRAL ENVELOPE PROTEINS;

EID: 33746152795     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cmr.0000215031.07941.ca     Document Type: Article

References (39)

1. Stoye JP, Coffin JM. RNA tumor viruses. In: Weiss R, Teich N, Varmus H, Coffin J, editors. Endogenous viruses. New York: Cold Spring Harbor Laboratory Press; 1985. pp. 357-404.
2. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921.
3. Wilkinson DA, Mager DL, Leong JA. Endogenous human retroviruses. In: Levy JA, editor. The Retroviridae. New York: Plemun Press; 1994. pp. 465-535.
4. Lower R, Lower J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 1996; 93:5177-5184.
5. Lower R, Boller K, Hasenmaier B, Korbmacher C, Muller-Lantzsch N, Lower J, et al. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci USA 1993; 90:4480-4484.
6. Boller K, Frank H, Lower J, Lower R, Kurth R. Structural organization of unique retrovirus-like particles budding from human teratocarcinoma cell lines. J Gen Virol 1983; 64:2549-2559.
7. Muster T, Waltenberger A, Grassauer A, Hirschl S, Caucig P, Romirer I, et al. An endogenous retrovirus derived from human melanoma cells. Cancer Res 2003; 63:8735-8741.
8. Büscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, Denner J. Expression of the human endogenous retrovirus HERV-K in melanomas and melanoma cell lines. Cancer Res 2005; 65:4172-4180.
9. Lower R, Tonjes RR, Korbmacher C, Kurth R, Lower J. Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol 1995; 69:141-149.
10. Magin C, Lower R, Lower J. cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-K. J Virol 1999; 73:9496-9507.
11. Magin C, Hesse J, Lower J, Lower R. Corf, the Rev/Rex homologue of HTDV/HERV-K, encodes an arginine-rich nuclear localization signal that exerts a trans-dominant phenotype when mutated. Virology 2000; 274: 11-16.
12. Boese A, Sauter M, Galli U, Best B, Herbst H, Mayer J, et al. Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein. Oncogene 2000; 19:4328-4336.
13. Galli UM, Sauter M, Lecher B, Maurer S, Herbst H, Roemer K, et al. Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors. Oncogene 2005; 28:28.
14. Armbruester V, Sauter M, Roemer K, Best B, Hahn S, Nty A, et al. Np9 protein of human endogenous retrovirus K interacts with ligand of numb protein X. J Virol 2004; 78:10310-10319.
15. Armbrüester V, Sauter M, Krautkraemer E, Meese E, Kleiman A, Best B, et al. A novel gene from the human endogenous retrovirus k expressed in transformed cells. Clin Cancer Res 2002; 8:1800-1807.
16. Dennis LK. Analysis of the melanoma epidemic, both apparent and real. Arch Dermatol 1999; 135:275-280.
17. Denner J. Immunosuppression by retroviruses: implications for xenotransplantation. Ann N Y Acad Sci 1998; 862:75-86.
18. Mangeney M, de Parseval N, Thomas G, Heidmann T. The full-length envelope of an HERV-H human endogenous retrovirus has immunosuppressive properties. J Gen Virol 2001; 82:2515-2518.
19. Ono M, Kawakami M, Ushikubo H. Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J Virol 1987; 61:2059-2062.
20. Magin-Lachmann C, Hahn S, Strobel H, Held U, Lower J, Lower R. Rec (formerly Corf) function requires interaction with a complex, folded RNA structure within its responsive element rather than binding to a discrete specific binding site. J Virol 2001; 75:10359-10371.
21. Phelps RC. Human endogenous retrovirus HERV-K envelope protein: expression in human tissues and cell lines (dissertation). Frankfurt am Main: Johann Wolfgang Goethe-Universität; 1997.
22. Denner J, Norley S, Kurth R. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients. Aids 1994; 8:1063-1072.
23. Tacke SJ, Bodusch K, Berg A, Denner J. Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation. Xenotransplantation 2001; 8:125-135.
24. Ozel M, Pauli G, Gelderblom HR. The organization of the envelope projections on the surface of HIV. Arch Virol 1988; 100:255-266.
25. Lower R, Lower J, Frank H, Harzmann R, Kurth R. Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. J Gen Virol 1984; 65:887-898.
26. Boller K, Konig H, Sauter M, Mueller-Lantzsch N, Lower R, Lower J, et al. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology 1993; 196:349-353.
27. Bannert N, Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci USA 2004; 101:14572-14579.
28. Gnann JW, Nelson JA, Oldstone MB. Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J Virol 1987; 61:2639-2641.
29. Denner J, Lower J, Lower R, Kurth R. Epitope mapping and antibody response against a human endogenous retrovirus (HERV-K) using synthetic peptides. J Cancer Res Clin Oncol 1993; 119(S1):294.
30. Denner J, Phelps RC, Lower J, Lower R, Kurth R. Antibody response of pregnant women, tumor and AIDS patients against the human endogenous retrovirus HERV-K. J Cancer Res Clin Oncol 1995; 121:5.
31. Fiebig U, Stephan O, Kurth R, Denner J. Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation? Virology 2003; 307:406-413.
32. Langhammer S, Fiebig U, Kurth R, Denner J. Neutralising antibodies against the transmembrane protein of feline leukaemia virus (FeLV). Vaccine 2005; 23:3341-3348.
33. Devash Y, Reagan K, Wood D, Turner J, Parrington M, Kang CY. Antibodies against AIDS proteins. Nature 1990; 345:581.
34. Reiss P, Lange JM, de Ronde A, de Wolf F, Dekker J, Debouck C, et al. Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1. J Med Virol 1990; 30:163-168.
35. Denner J. How does HIV induce AIDS? The virus protein hypothesis. J Hum Virol 2000; 3:81-82.
36. Lee JH, Torisu-Itakara H, Cochran AJ, Kadison A, Huynh Y, Morton DL, et al. Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes. Clin Cancer Res 2005; 11:107-112.
37. Tacke SJ, Kurth R, Denner J. Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation? Virology 2000; 268:87-93.
38. Mangeney M, Heidmann T. Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proc Natl Acad Sci USA 1998; 95:14920-14925.
39. Mangeney M, Pothlichet J, Renard M, Ducos B, Heidmann T. Endogenous retrovirus expression is required for murine melanoma tumor growth in vivo. Cancer Res 2005; 65:2588-2591.